Company Profile

Company History


Minophagen Pharmaceutical Co., Ltd. was founded in 1938 as a research-based pharmaceutical enterprise by Mr. Tokuma Utsunomiya who was president of the Company to 2000. Activity of the Company has been developed on research and development of glycyrrhizin preparations based on research works of Dr.Osamu Minouchi and Dr.Matsuzo Takahashi, bio-pharmacologists at Kyoto University, both co-founders of the Company. "Minophagen" is thus a hybrid name of Dr.Minouchi and "phagen" from the word phagocytosis on which their study and related drug development were focused.


The Company has ever since, in its growth to an integrated pharmaceutical company with an expansion of business scope and operational scale, concentrated its efforts on development of glycyrrhizin preparations. Wide use of Stronger Neo-Minophagen® C (SNMC®) in Japan and other countries represents the Company's dedications to and reputations among medical profession and medical community as well as its contribution to modern therapy to better control ailments such as allergic diseases and liver diseases. The Company is continuing its active research and development works in pursuit of service to the advancement of medicine of value for different diseases.

Campany Logo Founders

Page Top